Meng Qi Chen

Shanghai Bioveda Investment Management Consulting Co. Ltd. (BioVeda China) is an independent Chinese venture capital firm which was established by Dr. Zhi Yang when BioVeda Capital spun off their China Fund. Headquartered in Shanghai, BioVeda China is the first international life science venture capital firm in China and manages the BioVeda China Fund, backed by blue chip international institutional and corporate investors. The firm's Scientific Advisory Board, comprised of international experts from China and the West, supports BioVeda China by acting as a business and scientific bridge between companies in China and the West, linking finance and technology between the two markets.

Shanghai Bioveda Investment Management Consulting Co. Ltd. (BioVeda China) is an independent Chinese venture capital firm which was established by Dr. Zhi Yang when BioVeda Capital spun off their China Fund. Headquartered in Shanghai, BioVeda China is the first international life science venture capital firm in China and manages the BioVeda China Fund, backed by blue chip international institutional and corporate investors. The firm's Scientific Advisory Board, comprised of international experts from China and the West, supports BioVeda China by acting as a business and scientific bridge between companies in China and the West, linking finance and technology between the two markets.

Shanghai Bioveda Investment Management Consulting Co. Ltd. (BioVeda China) is an independent Chinese venture capital firm which was established by Dr. Zhi Yang when BioVeda Capital spun off their China Fund. Headquartered in Shanghai, BioVeda China is the first international life science venture capital firm in China and manages the BioVeda China Fund, backed by blue chip international institutional and corporate investors. The firm's Scientific Advisory Board, comprised of international experts from China and the West, supports BioVeda China by acting as a business and scientific bridge between companies in China and the West, linking finance and technology between the two markets.